Virologic and neurohistologic findings in dairy goats affected with natural scrapie

Recently described scrapie-like encephalopathies of animals: case definitions

Since 1986, naturally occurring scrapie-like encephalopathies have been described in the United Kingdom in domestic cattle, in five species of captive exotic bovids and in domestic cats. The disease in domestic cattle, bovine spongiform encephalopathy, has been characterised by all currently available diagnostic criteria as a transmissible spongiform encephalopathy or 'prion' disease, and has been shown to have a dietary origin. The pathology in the other species is also entirely consistent with the scrapie-like diseases. The contemporaneous occurrence in the UK of such disease in these species suggests a close epidemiological association. The diagnostic criteria of the scrapie-like encephalopathies of animals are reviewed in the light of experience with the recent extension of their natural host range.

Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics

Pharmacological treatment with polyanions or amphotericin B in hamsters with experimental scrapie reveals that it is possible to delay the appearance of the disease only when the drug is given before the invasion of the agent into the clinical target areas of the brain. We suggest such early treatment may be possible for individuals at high risk of acquiring the disease, such as healthy mutation-positive relatives of patients with familial Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome, or recipients of potentially contaminated pituitary-extracted human growth hormone.

Bovine spongiform encephalopathy (BSE): the current situation and research

Bovine spongiform encephalopathy (BSE), discovered in Great Britain in 1986, was to pose one of the most serious threats to the well-being of the British cattle industry this century. The disease is now established as a member of the group of diseases known as the sub-acute spongiform encephalopathies caused by unconventional, transmissible agents and which includes scrapie of sheep. It is from scrapie of sheep that it appears BSE has resulted though it is possible BSE may have existed in a sub-clinical form in cattle. The vehicle of transmission is meat and bone meal prepared from infected ruminant carcases and included in the protein concentrate rations of cattle, especially dairy cattle in which the disease predominates. Most animals become exposed as calves and the incubation period is typically 4-5 years with most cases occurring at this age. The increase in exposure of cattle to infection that resulted in disease in 1985/1986 was 1981/1982. The factors that contributed to this increase were an increasing sheep population, possibly an increase in the prevalence of scrapie and changes in the industrial processing of animal waste to prepare meat and bone meal. The clinical signs of BSE include abnormal behaviour, posture, gait and an increased sensitivity to visual and aural stimuli. There is loss of condition and milk yield. In only one of 28,197 cases of BSE confirmed by 10 May 1991 can feed be almost certainly ruled out as a source of infection. This therefore may be a singleton case of maternal transmission though we cannot be certain. Every other case so far has been exposed to meat and bone meal in the diet and thus resulted in an extended common source epidemic. A large research programme is underway to investigate the epidemiology, clinicopathology, transmission and molecular biological/genetic aspects of the disease. Much is collaborative between Institutes and Member States of the European Community, in which the disease, as in Britain, is notifiable. In Britain the lynch pin of control for animal health has been the ban established in July 1988 on feeling of ruminant protein to ruminant animals. Though there is no evidence that either BSE or scrapie is a hazard to humans, as a precautionary measure, suspect animals are compulsorily slaughtered and destroyed (except all brains are taken for diagnosis) with compensation being paid at 100% of value. Milk from such animals is also destroyed.(ABSTRACT TRUNCATED AT 400 WORDS)

Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation

We studied the targeting of spongiform lesions within the visual pathways after intraocular injection with the Fujisaki strain of Creutzfeldt-Jakob disease (CJD) virus. The first lesions were observed 18 weeks postinoculation in the most superficial layer of the superior colliculus and in the lateral geniculate body contralateral to the side of the inoculation. Asymmetrical lesions in the superior colliculus were found also in mice sacrificed at 19, 22, and 27 weeks postinoculation. These results demonstrate that CJD virus spreads within the CNS via central axons of the visual pathways following intraocular inoculation.

Polyclonal increase in certain IgG subclasses in mice persistently infected with the 87V strain of scrapie

Eight different combinations of seven strains of scrapie agent and the three known Sinc genotypes of mice were screened for changes in the concentration of IgG in serum. A single radial immunodiffusion assay was used to measure IgG throughout the incubation period which in different models ranged from an average of 125 days to longer than the maximum observation period of about 600 days. The only major changes occurred with the 87V strain of scrapie injected intracerebrally (i.c.) or intraperitoneally (i.p.) into mouse strains of the Sinc genotype p7p7. IgG concentration reached 1.5 to 2.0 times the control values in i.c. infected mice, which developed clinical disease after 270 to 320 days and also in i.p. infected mice, which did not develop the disease within the 600-day observation period. At very high IgG concentration, the increase was polyclonal; it involved the IgG 1 subclass more than the others and was accompanied by an increased rate of IgG clearance from serum. It is suggested that some scrapie infections of mice (and sheep) may upset the control of IgG production. The underlying mechanism may involve cell-pathogen interactions which are common to all scrapie infections, but only lead to gross changes in IgG in some combinations of agent strain and host genotype.

Influence of stereotaxically injected scrapie on neurotransmitter systems of mouse cerebellum

The 22L strain of scrapie was injected stereotaxically into the cerebellum of C57BL/6J mice to determine its effect on several cerebellar neurotransmitter systems during the early clinical stages of the disease. In this model vacuolar lesions are restricted to the cerebellum with no evidence of vacuolization in other brain regions. Although vacuolar lesions develop throughout all cell layers of the cerebellum, they are most severe in the granule cell layer. Modest but significant (P less than 0.01) reductions in cerebellar weight, glutamate decarboxylase activity, and in the affinity of the N6-[adenine-2,8-3H]cyclohexyladenosine binding sites, were observed in scrapie affected mice. The densities of the high- and low-affinity adenosine receptors were unaffected. Adenosine receptors in the cerebellum are highly localized to the axon terminals of the glutamatergic, GABA receptive granule cells. GABA, benzodiazepine, glutamate, and muscarinic cholinergic receptors were not significantly altered. In addition, the high-affinity uptake of glutamate, and the activity of choline acetyltransferase were not significantly changed. GABA high-affinity uptake was slightly increased. Even though the granule cell layer of the cerebellum had undergone severe vacuolation, only modest neurotransmitter changes were apparent. Although these results suggest a tenuous relationship between scrapie pathology and the integrity of neurotransmitter systems, it is possible that compensatory neurochemical changes in uncompromised neuronal populations may have masked potentially specific neurotransmitter effects.

Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously

Information was sought on the temporal distribution of transmissible mink encephalopathy virus in royal pastel mink inoculated subcutaneously with 10(3.0) 50% intracerebral lethal doses of the Idaho strain. As determined by intracerebral assay in mink, extremely little replication of the virus occurred during the preclinical stage of infection. It seemed largely limited to lymph nodes draining the site of inoculation. Virus first appeared in the central nervous system (CNS) at 20 weeks, when all mink were still clinically normal. Early spongiform degeneration, limited to the posterior sigmoid gyrus of the frontal cortex, was first found at 28 weeks, or a few weeks before onset of clinical disease in most of the mink. Once virus reached the CNS, where greater concentrations occurred than elsewhere, it appeared in many extraneural sites (spleen, liver, kidney, intestine, mesenteric lymph node, and submandibular salivary gland). These seemingly anomalous findings, especially the limited extraneural replication of virus as a prelude to infection of the CNS, suggest that mink are not natural hosts of the virus. The results of this study support the generally held view that transmissible mink encephalopathy arises from chance or inadvertent infection of ranch mink with an exogenous virus, most likely feed-borne wild scrapie virus.

Cerebrocortical degeneration in goats inoculated with mink-passaged scrapie virus

Widespread spongiform degeneration of the cerebral cortex occurred in four African pygmy goats that became affected with scrapie after intracerebral inoculation with scrapie virus (Suffolk sheep brain origin) that had been passed three times in ranch mink. The occurrence of such cerebrocortical degeneration was a distinct departure from the topographic pattern of neuropathologic changes that characterizes scrapie in sheep and goats. But the cortical lesion was identical to the one found in goats that became affected with a disease otherwise indistinguishable from scrapie after intracerebral inoculation with transmissible mink encephalopathy (TME) virus that had been passed twice in mink. If TME originated from infection with wild scrapie virus, as is generally thought, then the viruses used in these two instances would be equivalent in their passage history in this aberrant host. Given this similarity, the common occurrence of the cortical lesion is thought to be consistent with the view that TME virus almost certainly is scrapie virus whose biologic properties became altered by chance passage in ranch mink.

Creutzfeldt-Jakob Disease. Possible transmission to humans by consumption of wild animal brains

Although the natural mode of spread of the agent responsible for Creutzfeldt-Jakob disease is unknown, several reports suggest oral transmission through consumption of contaminated food or brain. This report summarizes four cases of Creutzfeldt-Jakob disease in which a history of eating the brains of wild goat or squirrel was obtained. These cases support the hypothesis of possible acquisition of Creutzfeldt-Jakob disease by ingestion of the agent from a presumptive reservoir in the central nervous system of wild animals.

Intraneuronal enzymic inclusions in the histological diagnosis of scrapie

Cumulative results are presented of histopathological and enzyme histochemical findings in sheep naturally or experimentally infected with scrapie compared with healthy controls or animals with other diseases. Two hundred and sixty-eight sheep were examined, including 210 cases of clinical or suspected scrapie. According to the nature and distribution of histopathological changes, especially neuropil vacuolation and neuronal vacuoles, scrapie-affected sheep were classified into groups. In particular, examination of medulla oblongata revealed a consistently different pattern of lesions between natural scrapie (type A) and experimental scrapie (type B). Cytoplasmic enzymic inclusions demonstrated by methods for beta-glucuronidase and for acid phosphatase were regularly found in neurones from scrapie sheep but not from control animals. They appeared to be more prevalent in type B than in type A scrapie and were demonstrable even in tissue affected by post-mortem autolysis. The distribution of enzymic inclusions ranged from Betz cells of cerebral cortex to grey matter of the lumbar region of spinal cord. The detection of enzymic inclusions is a useful diagnostic criterion and has been incorporated into histological diagnostic procedures for scrapie.

Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve

Previous studies of peripherally injected mouse scrapie suggested that invasion of the CNS occurs initially in mid-thoracic cord by neural spread of infection from spleen and other visceral sites of extraneural replication. We now show that infection of the left sciatic nerve leads to direct spread of infection to brain (at a rate of approximately 1.0-2.0 mm/day), bypassing the need for extraneural replication and thus producing shorter incubation periods. However, the efficiency of intraneural infection is low. It can be increased by crush injury or by the injection of lysophosphatidyl choline, both of which temporarily increase the surface area of axolemma exposed to inoculum. Once infection is established, agent seems to spread throughout the nervous system but, at the clinical stage of disease, the titres in the PNS are much lower than in the CNS.

Novel proteinaceous infectious particles cause scrapie

After infection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats. Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity. Although the scrapie agent is irreversibly inactivated by alkali, five procedures with more specificity for modifying nucleic acids failed to cause inactivation. The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a molecular weight of 50,000 or less. Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term "prion" is proposed to denote a small proteinaceous infectious particle which is resistant to inactivation by most procedures that modify nucleic acids. Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.